Mehdi, Ali A <br/><br/>
Antiphospholipid syndrome: pathogenesis and a window of treatment opportunities in the future.  [electronic resource] 

 -  European journal of clinical investigation  May 2010 
 - 451-64 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1365-2362 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2362.2010.02281.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Annexin A2--antagonists & inhibitors<br/>Anti-Inflammatory Agents--therapeutic use<br/>Antibodies, Antiphospholipid--immunology<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Murine-Derived<br/>Antiphospholipid Syndrome--etiology<br/>Complement Activation<br/>Humans<br/>Hydroxychloroquine--therapeutic use<br/>Immunologic Factors--therapeutic use<br/>Monocytes<br/>NF-kappa B--physiology<br/>Platelet Activation<br/>Rituximab<br/>Thromboplastin--antagonists & inhibitors<br/>p38 Mitogen-Activated Protein Kinases--physiology